WO2007023298A3 - Anticorps - Google Patents
Anticorps Download PDFInfo
- Publication number
- WO2007023298A3 WO2007023298A3 PCT/GB2006/003187 GB2006003187W WO2007023298A3 WO 2007023298 A3 WO2007023298 A3 WO 2007023298A3 GB 2006003187 W GB2006003187 W GB 2006003187W WO 2007023298 A3 WO2007023298 A3 WO 2007023298A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibodies
- binds
- antibody
- fragment
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne un anticorps ou un fragment de celui-ci qui se lie à une région extracellulaire formant un pore d'un canal ionique sodique. Les anticorps de l'invention peuvent être utilisés dans des méthodes de traitement.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517487.5A GB0517487D0 (en) | 2005-08-26 | 2005-08-26 | Antibodies |
GB0517487.5 | 2005-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007023298A2 WO2007023298A2 (fr) | 2007-03-01 |
WO2007023298A3 true WO2007023298A3 (fr) | 2007-05-31 |
Family
ID=35198463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/003187 WO2007023298A2 (fr) | 2005-08-26 | 2006-08-25 | Anticorps |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0517487D0 (fr) |
WO (1) | WO2007023298A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986694B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Targeting human nav1.7 variants for treatment of pain |
US8992927B1 (en) | 2014-07-15 | 2015-03-31 | Kymab Limited | Targeting human NAV1.7 variants for treatment of pain |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6095368B2 (ja) * | 2009-10-27 | 2017-03-15 | ユセベ ファルマ ソシエテ アノニム | 機能改変するNav1.7抗体 |
JP6335152B2 (ja) * | 2009-10-27 | 2018-05-30 | ユセベ ファルマ ソシエテ アノニム | イオンチャネルに対する抗体 |
US9234037B2 (en) | 2009-10-27 | 2016-01-12 | Ucb Biopharma Sprl | Method to generate antibodies to ion channels |
GB0922434D0 (en) | 2009-12-22 | 2010-02-03 | Ucb Pharma Sa | antibodies and fragments thereof |
US9340590B2 (en) | 2011-03-16 | 2016-05-17 | Amgen Inc. | Potent and selective inhibitors of NaV1.3 and NaV1.7 |
WO2014165277A2 (fr) | 2013-03-12 | 2014-10-09 | Amgen Inc. | Inhibiteurs sélectifs et puissants de nav1.7 |
US9636418B2 (en) | 2013-03-12 | 2017-05-02 | Amgen Inc. | Potent and selective inhibitors of NAV1.7 |
MX2015010749A (es) | 2013-03-14 | 2015-11-30 | Regeneron Pharma | Anticuerpos humanos para nav1.7. |
FR3007762B1 (fr) | 2013-06-28 | 2015-09-04 | Galderma Res & Dev | Anticorps diriges contre le canal sodique nav1.9 humain et leurs utilisations pour le diagnostic des maladies cutanees inflammatoires |
FR3007763A1 (fr) * | 2013-06-28 | 2015-01-02 | Galderma Res & Dev | Anticorps diriges contre le canal sodique nav1.9 humain et leurs utilisations en diagnostic |
FR3007656B1 (fr) | 2013-06-28 | 2015-06-26 | Galderma Res & Dev | Modulateurs du canal sodique nav1.9 pour le traitement d'une maladie cutanee inflammatoire et methodes diagnostiques |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
WO2018083248A1 (fr) | 2016-11-03 | 2018-05-11 | Kymab Limited | Anticorps, combinaisons comprenant des anticorps, biomarqueurs, utilisations et procédés |
GB201711208D0 (en) | 2017-07-12 | 2017-08-23 | Iontas Ltd | Ion channel inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6573067B1 (en) * | 1998-01-29 | 2003-06-03 | Yale University | Nucleic acid encoding sodium channels in dorsal root ganglia |
-
2005
- 2005-08-26 GB GBGB0517487.5A patent/GB0517487D0/en not_active Ceased
-
2006
- 2006-08-25 WO PCT/GB2006/003187 patent/WO2007023298A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6573067B1 (en) * | 1998-01-29 | 2003-06-03 | Yale University | Nucleic acid encoding sodium channels in dorsal root ganglia |
Non-Patent Citations (9)
Title |
---|
BRACKENBURY WJ, CHIONI A-M, DISS JKJ, DJAMGOZ MBA: "The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells", BREAST CANCER RES TREAT, vol. 101, 13 July 2006 (2006-07-13), pages 149 - 160, XP002415452 * |
CHIONI ET AL: "A novel polyclonal antibody specific for the Nav1.5 voltage-gated Na<+> channel 'neonatal' splice form", JOURNAL OF NEUROSCIENCE METHODS, ELSEVIER SCIENCE PUBLISHER B.V., AMSTERDAM, NL, vol. 147, no. 2, 30 September 2005 (2005-09-30), pages 88 - 98, XP005047799, ISSN: 0165-0270 * |
FRASER SCOTT P ET AL: "Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 AUG 2005, vol. 11, no. 15, 1 August 2005 (2005-08-01), pages 5381 - 5389, XP002415107, ISSN: 1078-0432 * |
JULIE R GRALOW: "Optimizing the treatment of metastatic breast cancer", BREAST CANCER RESEARCH AND TREATMENT, KLUWER ACADEMIC PUBLISHERS, BO, vol. 89, no. Suppl 1, 1 January 2005 (2005-01-01), pages S9 - S15, XP019274747, ISSN: 1573-7217 * |
KRAFTE D S ET AL: "Stable expression and functional characterization of a human cardiac Na<+> channel gene in mammalian cells", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 27, no. 2, February 1995 (1995-02-01), pages 823 - 830, XP004537549, ISSN: 0022-2828 * |
MAIER SEBASTIAN K G ET AL: "An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 19 MAR 2002, vol. 99, no. 6, 19 March 2002 (2002-03-19), pages 4073 - 4078, XP002415110, ISSN: 0027-8424 * |
THOMSEN W J ET AL: "Localization of the receptor site for alpha-scorpion toxins by antibody mapping: implications for sodium channel topology.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA DEC 1989, vol. 86, no. 24, December 1989 (1989-12-01), pages 10161 - 10165, XP002415108, ISSN: 0027-8424 * |
XU SHANG-ZHONG ET AL: "Generation of functional ion-channel tools by E3 targeting.", NATURE BIOTECHNOLOGY OCT 2005, vol. 23, no. 10, October 2005 (2005-10-01), pages 1289 - 1293, XP002415111, ISSN: 1087-0156 * |
YU FRANK H ET AL: "Overview of the voltage-gated sodium channel family.", GENOME BIOLOGY 2003, vol. 4, no. 3, 2003, pages 207, XP002415109, ISSN: 1465-6914 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986694B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Targeting human nav1.7 variants for treatment of pain |
US8992927B1 (en) | 2014-07-15 | 2015-03-31 | Kymab Limited | Targeting human NAV1.7 variants for treatment of pain |
Also Published As
Publication number | Publication date |
---|---|
WO2007023298A2 (fr) | 2007-03-01 |
GB0517487D0 (en) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007023298A3 (fr) | Anticorps | |
CY2018027I2 (el) | Ανταγωνιστικα αντισωματα il-17 | |
IL197459A0 (en) | Humanized proteins, including antibodies and methods for producing the same | |
WO2006084264A3 (fr) | Variants d'anticorps et utilisations | |
IL227753A0 (en) | A qualified antibody or antibody residue | |
IL206709A0 (en) | Il-31 monoclonal antibodies | |
IL242434B (en) | Antibody molecules with selectivity for 6-il of human origin | |
SG10201404801YA (en) | Monoclonal antibody | |
IL191617A (en) | An antibody linked to polyubiquitin, a method for its preparation, a pharmaceutical preparation containing it and its uses | |
HRP20120606T1 (en) | Anti-il-17 antibodies | |
SG170091A1 (en) | Anti-5t4 antibodies and uses thereof | |
WO2009052400A8 (fr) | Anticorps qui se lient à la ngal des mammifères et utilisations de ceux-ci | |
PL1974017T5 (pl) | Środki i sposoby do wpływania na stabilność komórek wytwarzających przeciwciała | |
EP1860120A4 (fr) | Procédé permettant d'améliorer un anticorps | |
WO2008048519A3 (fr) | Anticorps se liant aux épitopes de cxcr7 | |
MX2010001237A (es) | Nuevos anticuerpos. | |
IL185781A0 (en) | Antibodies against candida antigens | |
EP1789087A4 (fr) | Fragment d'anticorps génétiquement modifié qui se lie à un antigène de manière irréversible | |
WO2006116319A3 (fr) | Reactifs se liant au ccx-ckr2 | |
WO2006100430A3 (fr) | Polypeptides | |
EP1922412A4 (fr) | Conjugues d'anticorps humanises et procedes correspondants, essais biologiques, reactifs et trousses | |
WO2007002525A3 (fr) | Anticorps de tomoreguline et leurs utilisations | |
ZA200707838B (en) | Antibodies against Candida antigens | |
EP1712564A4 (fr) | Anticorps monoclonal anti-nc1 | |
WO2007002096A3 (fr) | Methodes et compositions permettant de cibler ifnar2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06779218 Country of ref document: EP Kind code of ref document: A2 |